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Forty patients with sustained tachycardia occurring 3 to
65 days after myocardial infarction underwent pro-
grammed ventricular stimulation within 3 months of the
infarction. Patients were characterized clinically by a
complicated initial 48 hours of hospitalization for their
acute infarction (85% of study group). The development
of bundle branch block in association with infarction
occurred with an unusually high frequency (32%). Ven-
tricular tachycardia similar in configuration to sponta-
neous arrhythmia was induced with programmed ven-
tricular stimulation in 33 (83%) of the 40 patients. In
IS (45%) ofthese 33 patients, additional morphologically
distinct ventricular tachycardia not seen clinically was
initiated. The induction of ventricular tachycardia was
not significantly related to the time after myocardial
infarction at which spontaneous ventricular tachycardia
was initially observed.
Only 20 of the 40 patients are alive after a mean
Sustained ventricular tachyarrhythmias that occur late (after
the initial 48 hours) in the hospital course of an acute myo-
cardial infarction are associated with a poor prognosis (1-4).
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follow-up period of 20 ± IS months. Twelve of the 20
deaths were sudden cardiac deaths. Sixteen of the 33
patients with inducible ventricular tachycardia died; 8
of the 16 deaths were sudden. By comparison, four of
the seven patients with no inducible ventricular tachy-
cardia died (probability [pI = not significant), all sud-
denly. The mode of therapy did not influence subsequent
survival.
It appears that in patients with sustained ventricular
tachycardia occurring more than 48 hours after a recent
myocardial infarction, ventricular tachycardia similar
to that clinically observed can usually be induced by
programmed stimulation. In addition, multiple mor-
phologically distinct ventricular tachycardias, some of
which have not been previously observed, are frequently
induced. Finally, the prognosis for survival is poor , re-
gardless of inducibility or mode of therapy, and may in
part be related to a changing arrhythmia substrate.
Extensive infarction usually precedes arrhythmia develop-
ment (1,2). Arrhythmias refractory to therapy are frequently
encountered and optimal management has been difficult to
define (1,2) . The electrophysiologic mechanism for ven-
tricular tachycardia in the early postinfarction period has
not been extensively evaluated in human subjects. Data from
canine studies and preliminary evidence in patients suggest
a reentrant mechanism (5-7).
We retrospectively evaluated the clinical history and elec-
trophysiologic findings of 40 patients who developed sus-
tained ventricular tachycardia between 3 and 65 days after
myocardial infarction . We sought to: I) further define clin-
ical features that characterize those patients at high risk for
developing life-threatening ventricular arrhythmias; 2) de-
fine the probable mechanism of the tachycardia based on
the response to programmed stimulation; and 3) determine
the prognosis for survival and its relation to both the ability
to induce the arrhythmia at the time of electrophysiologic
study and subsequent medical or surgical management.
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Methods ferred from other institutions for evaluation of their
Study Patients (TabLe 1)
arrhythmias.
Criteria for infarction. The criteria for infarction in-
There were 38 men and 2 women in the study group, eluded at least two of the following : ischemic chest pain
ranging inagefrom 35to 73years. All40 patients developed lasting longer than 30 minutes, charcteristic changes of serum
at least one documented episode of sustained ventricular enzymes and evolving typical QRS-T changes in serial elec-
tachycardia within 3 to 65 days after a definite myocardial trocardiograms. Previous myocardial infarction was diag-
infarction. All patients underwent electrophysiologic study, nosed if the patient had previously been hospitalized for a
which included programmed ventricular stimulation after documented myocardial infarction.
the development of the ventricular arrhythmia. Electro- Clinical evaluation. The records for each patient from
physiologic studies were performed within3 months of myo- the initial 48 hours of hospitalization for acute infarction
cardial infarction. Thirty-three of the 40 patients were re- were reviewed to detect possible early harbingers of sub-
Table 1. Clinical Data in 40 Patients With Sustained Ventricular Arrhythmia After Infarction
Complications No. of Stenosed
Age(yr) MI Withm 48 Hours Days From Days From Episodes EF Coronary LV
Case Sex Site of MI MI toVT MI to EPS VTiVF (%) Arteries Aneurysm
I 57M Ant VT/VF,BBB,CHF,P 5 26 > 5 27 2 Yes (ant-ap)
2 58M Ant CHF 8 24 > 5 25 2 No
3 61M Inf BBB,CHF 23 34 > 5 35 3 No
4 35M Inf None 2\ 34 \ 49 I No
5 59M Inf CHF 10 64 4 25 I Yes (ap)
6 65M Ant BBB,CHF 10 21 I 30* Yes* (ant-ap)
7 51M Anrt CHF 24 35 > 5 20 2 No
8 52M Inf None 17 67 3 II 3 No
9 59M Ant BBB \2 53 4 10* Yes* (ant-ap)
10 12M Ant CHF 29 60 4 24 2 Yes (ant-ap)
II 63F Inf None 4 II 2 16* Yes (ap)
12 45F Inf None 7 28 > 5 40* No*
13 68M Ant BBB 34 60 3 22 2 Yes (ant-ap)
14 36M Inf CHF 35 90 > 5 25* No*
15 38M Inf CHF 5 25 3 36 I No
16 55M Ant CHF \4 50 > 5 38 3 Yes (ap)
17 58M Ant Low BP,CHF 7 42 > 5 25 2 Yes (ant-ap)
18 63M Ant P 65 75 2 25* Yes* (ap)
19 51M Ant None 43 52 I 40 2 No
20 73M Ant BBB 14 26 > 5 40* No*
21 65M Inft None 4 23 2 40 2 Yes (ap)
22 56F Ant Low BP,CHF,VTiVF,P 3 4 3 25 I Yes (ant-ap)
23 49M Ant BBB 21 37 > 5 22 3 Yes (ant-ap)
24 64M Inf CHF.VSD 58 66 I 29 3 Yes (inf-bas)
25 49M Ant BBB 15 80 > 5 15 I Yes (ap)
26 54M Ant CHF \4 90 3 45 I Yes (ant-up)
27 49M Ant VTiVF,BBB,CHF,P 30 45 > 5 28 2 Yes (ap)
28 57M Inf Low BP,P,CHF 35 76 > 5 40 3 Yes (ap)
29 61M Inf VTiVF 47 70 2 38 3 Yes (inf-bas)
30 58M Inf VTiVF,CHF 36 40 I 42 2 No
31 57M Ant BBB.CHF 7 75 > 5 49 I Yes (ant-ap)
32 50M Ant CHF,P 21 48 > 5 20 2 Yes (ant-ap)
33 61M Inf Low BP,VTiVF,CHF 20 35 > 5 14 2 Yes (ap)
34 12M Ant None II 50 > 5 33 3 No
35 56M Ant BBB 3 30 > 5 27 2 Yes (ant-ap)
36 35M Inf VTiVF 7 39 2 34 2 Yes (ap)
37 58M Ant BBB,CHF 7 28 > 5 32 2 No
38 50M Inf CHF 12 30 > 5 23 3 Yes (ant-ap)
39 66F Ant VT 30 45 2 15 I Yes (ant-ap)
40 57M Ant BBB 25 45 > 5 49 I Yes (ant-ap)
"Ejection fraction and presence of left ventricular aneurysm determmcd by gated blood pool scan; ts ubendocardial myocardial infarction ,
Ant = anterior; ant-ap = anteroapical; ap = apical; BBB = bundle branch block; CHF = congestive heart failure; EPS = electrophysiologicstudy;
F = female; Inf = inferior; Inf-bas = mferobasrlar; Low BP = hypotension requiring pharmacologic mtervention; M = male; M = myocardial
infarction; No. = number, P = pencardius; VTiVF = ventricular tachycardra/tlbrillanon.
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sequent arrhythmia development. Specifically, the occur-
rence of major ventricular arrhythmias, bundle branch block,
hypotension that required pharmacologic intervention, a
pericardial friction rub or severe congestive heart failure
(Killip class III or IV) (8) were noted.
Laboratory evaluation. Left ventricular cineangiogra-
phy and selective coronary arteriography were performed in
34 of the 40 patients. Significant obstructive coronary le-
sions were defined as 70% or more luminal narrowing. A
left ventricular aneurysm was noted if segmental paradoxic
wall motion was present. Ejection fraction was determined
by the area-length method from the left ventriculogram ob-
tained in the 30° right anterior oblique position. In the re-
maining six patients, left ventricular ejection fraction and
the presence of left ventricular aneurysm were determined
by gated equilibrium radionuclide angiography.
Electrophysiologic Study
Thirty-seven of the 40 patients were studied after all
antiarrhythmic agents were stopped for 48 hours. In the
remaining three patients (Cases 2, 24 and 33), baseline
electrophysiologic studies were performed while they were
receiving antiarrhythmic therapy which, although decreas-
ing the frequency of tachycardia, did not completely sup-
press the clinical occurrence of ventricular tachycardia.
Routinely, electrode catheters were inserted percutaneously
and positioned using fluoroscopic guidance in the high right
atrium, at the atrioventricular junction for recording of the
His bundle electrogram, in multiple right ventricular sites,
and in six patients, in multiple left ventricular sites. During
serial electrophysiologic studies to test efficacy of antiar-
rhythmic regimens, only one electrode catheter was rou-
tinely employed. Two catheters (one atrial and one ven-
tricular) were used if ventriculoatrial dissociation was present.
By simultaneously pacing the atria and ventricles, a stable
ventricular paced rhythm not interrupted by supraventricular
capture beats was ensured during programmed ventricular
stimulation. .Number 6 French quadripolar electrode cath-
eters (USCI) were used in all these instances except for
recording of the His bundle electrogram, in which case a 7
French tripolar catheter was employed.
Stimulation was performed with a custom-designed, pro-
grammable stimulator (Bloom Associates Ltd.). Using a
constant current source, rectangular impulses of I ms du-
ration were delivered at twice diastolic threshold. Record-
ings were made using a 16 channel physiologic recorder
(VR-16, Electronics for Medicine) and real-time records
were obtained with an ink jet recorder (Siemens Elema
Mingograf) at a paper speed of 100 to 250 mm/s.
Stimulation Protocol
In all patients, programmed ventricular stimulation con-
sisted of single and double premature ventricular extrasti-
muli at two ventricular paced cycle lengths (usually 600 and
400 ms) from at least two right ventricular sites. If the
tachyarrhythmia was not inducible, all but 1 patient under-
went: 1) right ventricular stimulation with three ventricular
extrastimuli (10 patients), or 2) repeat single and double
ventricular extrastimuli from the left ventricle (6 patients),
or both 1) and 2) or 3) repeat right ventricular stimulation
with single and double ventricular extrastimuli after the
administration of isoproterenol to increase sinus rate to 120
beats/min (1 patient). Stimulation with triple right ventric-
ular extrastimuli and left ventricular stimulation has been
demonstrated to increase inducibility of sustained ventric-
ular arrhythmias (9,10). Isoproterenol was not routinely used
in those patients with recent myocardial infarction. Al-
though isoproterenol may occasionally facilitate the induc-
tion of ventricular tachycardia in patients with chronic coro-
nary artery disease, its safety in the settingof recent myocardial
infarction has not been established (11). Stimulation com-
parable with that used at baseline study with respect to
number of extrastimuli and site of stimulation was employed
in each patient during all follow-up studies.
Clinical Management
In this study, we separately assessed the management
and clinical course of patients with and without inducible
arrhythmias at the time of electrophysiologic study.
Inducible arrhythmia: medical management. Medical
management was guided by both the clinical response of
the antiarrhythmic agent in effectively suppressing spon-
taneous recurrent sustained ventricular tachyarrhythmias and
the results of electrophysiologic testing. If the antiar-
rhythmic agent failed to prevent spontaneous occurrence of
the arrhythmia at maximally tolerated doses, it was not
tested in the electrophysiologic laboratory.
An antiarrhythmic agent that prevented induction of the
ventricular tachyarrhythmia was considered to be an effec-
tive agent (Tables 1 and 2, Cases 15 to 21). We routinely
tested the following agents: procainamide, 1 to 2.5 g intra-
venously at 50 mg/min followed by a 4 to 10 mg/min con-
tinuous infusion; lidocaine, 3 to 5 mg/kg over a 10 minute
period followed by a continuous infusion of 4 mg/min; quin-
idine sulfate, 300 to 600 mg orally every 6 hours; disopyr-
amide, 100 to 300 mg orally every 6 hours and phenytoin,
300 to 500 mg orally once a day. All orally administered
drugs were given for at least five half-lives to achieve steady
state levels up to the maximally tolerated doses. In 10 pa-
tients, an experimental antiarrhythmic agent was also tested.
These agents included: amiodarone, 1,400 mg orally once
a day for an initial loading period of 7 to 21 days followed
by a maintenance dose of 400 to 800 mg/day; or mexiletine,
100 to 300 mg orally every 8 hours. Combinations of an-
tiarrhythmic agents were also employed; the most common
of these was amiodarone with quinidine or pronestyl.
An antiarrhythmic agent that prevented clinical occur-
rence during a 2 to 4 week period of observation of the
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tachycardia but did not prevent its induction in the electro-
physiologic laboratory was considered a possibly effective
agent (Table 2, Cases 4 to 14), Because data from our
laboratory and others suggested a dissociation between in-
ducibility of the arrhythmia during electrophysiologic test-
ing and clinical occurrence of arrhythmia after treatment
with amiodarone, our patients, most frequently were taking
amiodarone if the tachycardia was still inducible at the time
of discharge (Table 2) (12,13). In three patients (Tables 1
and 2, Cases 1 to 3) managed medically, repeat electro-
physiologic testing was not performed.
Inducible arrhythmias: surgical management. The
surgical therapy routinely employed (Tables 1 and 2, Cases
22 to 33) was endocardial resection guided by endocardial
and epicardial mapping with or without aneurysmectomy or
coronary artery bypass grafting. The details of this proce-
dure have been extensively reported previously (14-16). In
one patient (Case 33), nondirected surgery (aneurysmec-
tomy without endocardial resection) was the only surgical
procedure. The decision to proceed to surgery was based
on the clinical failure of all antiarrhythmic agents or the
persistent ability to induce a rapid, poorly tolerated ven-
tricular tachycardia during electrophysiologic study, or both.
In one patient (Case 24), early surgery was elected because
of the concurrent finding of ventricular septal defect with
significant left to right shunting.
No inducible arrhythmia: medical management. If no
inducible arrhythmia was initiated at the time of electro-
physiologic study, specific antiarrhythmic therapy was not
recommended. Antiarrhythmic therapy, however, was ini-
Table 2. Course of 33 Patients With Inducible Ventricular Tachycardia
Inducibility
Medical Surgical at Follow-Up
Case Treatment Treatment DIscharge (mo)
I Quinidine" None * t Hospital
2 Procainarmde" None t Hospital
3 Disopyramide,* None * t (16)
phenytoin
4 Disopyrarmde None Altve (53)
5 Procainamide None t Ca (6)
6 Quinidine None Alive (5)
7 Amiodarone, None t CHF (7)
procainamide
8 Amiodarone None Alive (16)
9 Amiodarone None Alive (13)
10 Amiodarone None Alive (16)
II Amiodarone None t (3)
12 Amiodarone None Alive (12)
13 Amiodarone None Altve (9)
14 Amiodarone, None Alive (4)
procainamide
15 Quinidine None NI Alive (13)
16 Qurrudine None NI t (30)
17 Procainamide None NI t (8)
18 Quinidine None NI Alive (25)
19 Mexiletme None NI Alive (5)
20 Mexiletine, None NI Alive (13)
quinidine
21 Quinidine None NI Alive (3)
22 None Anx,ER NI Alive (32)
23 None Anx,ER,CAB toper
24 None Anx,EF,CAB,VSD * toper
25 None Anx,ER NI Aliv (24)
26 None Anx,ER NI Alive (8)
27 Quinidine Anx,ER,CAB NI t CHF (20)
28 Disopyramide Anx,ER,CAB * toper
29 None Anx,ER,CAB NI Alive (42)
30 None Anx,ER,CAB toper
31 None Anx,ER NI t (I)
32 Amiodarone Anx,ER I t pneumoma (4)
33 Procainamide Anx * t Hosp VT
*No repeat electrophysiologic studies performed, tsudden death, tnonsudden death.
Anx = aneurysectomy; Ca = carcinoma; CAB = coronary artery bypass grafting; CHF = refractory congestive heart failure; ER = endocardial
resection; Hosp VT = death m hospital from ventricular tachycardia; I = inducible; NI = not inducible; Oper = perioperative death.
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tiated at the discretion of the patient's private physician
(Table 3).
No inducible arrhythmia: surgical management. In
two patients, despite the fact that no inducible ventricular
tachyarrhythmia was initiated at the time of electrophysi-
ologic study, repeated long bursts of nonsustained ventric-
ular tachycardia (5 to 20 beats in duration) were clinically
observed and proved refractory to medical therapy. Because
of the nonsustained ventricular tachycardia and preceding
history of life-threatening sustained ventricular tachyar-
rhythmias, endocardial resection, guided by endocardial and
epicardial mapping of the nonsustained ventricular tachy-
cardia, was performed.
Follow-Up and Data Analysis
Follow-up information was obtained at the time of revisit
to the Arrhythmia Evaluation Center at the Hospital of the
University of Pennsylvania or, when patients lived a long
distance from the center, by telephone conversation with
the patient and patient's private physician.
Statistical analyses were performed using Student's t test
for unpaired data and chi-square analysis when appropriate.
All numerical values are expressed as mean ± standard
deviation unless otherwise specified.
Results
Clinical features (Table 1). Twenty-three (58%) of the
40 patients had transmural anterior myocardial infarction
and 15 (38%) had transmural inferior infarction. The two
remaining patients had nontransmural infarction (one an-
terior and one inferior). Both nontransmural infarctions were
marked electrocardiographically by persistent symmetric T
wave inversions without the development of Q waves. Ten
(25%) of the 40 patients had a history of a previously doc-
umented myocardial infarction.
During the first 48 hours ofhospitalization, 34 (85%) of
the 40 patients had a major complication with their infarc-
tion. In 13 (32%), the infarction (12 anterior and I inferior)
was complicated by right or left bundle branch block. In
addition, congestive heart failure was observed in 20 pa-
tients (50%), major ventricular arrhythmias in 7 (18%),
hypotension requiring pharmacologic support in 5 (12%)
and pericarditis in 5 (12%).
Angiographic evidence of severe multivessel coronary
artery disease and impaired left ventricular function was
commonly observed in the 34 patients who underwent car-
diac catheterization. Single, double and triple vessel ste-
nosis occurred in 9 (26%), 15 (44%) and 10 (30%) patients,
respectively. Twenty-five of the 40 patients had a left ven-
tricular aneurysm. Left ventricular ejection fraction mea-
sured in all 40 patients ranged from 10 to 49% (mean 30%,
normal 55% or greater). In 20 of the patients, the ejection
fraction was 25% or less.
Characteristicsof spontaneous ventricular tachycardia.
The onset of sustained ventricular tachycardia occurred 3
to 65 days (mean 20 ± 15) after admission to the hospital
for myocardial infarction (Fig. 1). Of the 40 patients, 16
had at least one episode of ventricular tachycardia that de-
generated to ventricular fibrillation.
The majority of the patients had multiple (>5) episodes
of ventricular tachycardia (Table 1). We were able to char-
acterize the tachycardias as having either a right or a left
bundle branch block configuration in 38 of 40 patients. In
20 of the 38 patients, the tachycardias had only a right
bundle branch block configuration, and in 15 only a left
bundle branch block configuration; in 3 patients, both right
and left bundle branch block tachycardia configurations were
noted. The tachycardia rate was determined in all 40 pa-
Figure 1. Relation of the time after myocardial infarction (MI)
for the development of spontaneous ventricular tachycardia (VT)
to subsequent inducibility during programmed stimulation in 40
patients. All electrophysiologic studies were performed within 3
months of infarction. Subsequent induction of ventricular tachy-
cardia was not significantly (p>0.05 using 2 x 4 contingency
tableand Fisherexact test) relatedto timeof onsetof spontaneous
arrhythmia after myocardial infarction.
5
Table 3. Course of Eight Patients With No Inducible
Ventricular Tachycardia
Medical Surgical Follow-up
Case Treatment Treatment (mo)
34 None None t (41)
35 None None Alive (7)
36 Procainamide None Alive (10)
37 Procamamide None t (28)
38 Procainamide None t (14)
39 None Anx,ER Alive (42)
40 None Anx,ER t Oper-VT
Anx = aneurysectomy; ER = endocardial resection; Oper-VT = sus-
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tients. The rate was greater than 220 beats/min in 13 patients
(33%), between 180 and 220 beats/min in 15 patients (38%)
and less than 180 beats/min in only 12 (30%), Loss of
consciousness was associated with the development of the
tachycardia in 27 of the 40 patients.
Results of electrophysiologic testing. Electrophysio-
logic studies were performed within 3 months of myocardial
infarction (mean 45 ± 21days, range 4 to 90). Thirty-three
patients (83%) had reproducible initiation of sustained ven-
tricular tachycardia with programmed stimulation. In the
remaining seven patients, no sustained ventricular arrhyth-
mias were inducible. Four of these seven patients received
both right and left ventricular stimulation; one had repeat
right ventricular stimulation after administration of isopro-
terenol, one received three ventricular extrastimuli from two
right ventricular sites and one patient received only single
and double ventricular extrastimuli from multiple right ven-
tricular sites (Case 40).
Patients with inducible ventricula r tachycardia, when
compared with those with no inducible ventricular tachy-
cardia , did not differ significantly with respect to the extent
of cardiac disease as indexed by ejection fraction (29 versus
31%), number of coronary vessels stenosed (2.2 versus 2)
or the presence of left ventricular aneurysm (50 versus 71%).
Of particular note. inducibility was not signifi cantly related
to the time after myocardial infarction at which spontaneous
ventricular tachycardia was first observed (Fig. I). Even In
the 20 patients with ventricular tachycardia occurring 3 to
14 days after infarction, 15 (75%) had subsequent initiation
of their ventricular tachycardia during electrophysiologic
study.
Single , double and triple right ventricular extrastimuli
initiated the veniricular tachycardia ill 8, 14 and 9 patients,
respectively. Single and double left ventricular extrastimuli
were required in one patient each. In 20 of the 33 patients,
the tachycardia could be terminated reproducibly by rapid
ventricular pacing. In the remaining patients, electrical
countershock was required to restore normal rhythm because
of rapid hemodynamic collapse associated with the tachy-
cardia. A tachycardia configuration similar to that of the
spontaneous tachycardia was induced in all 33 patients in
whom programmed ventricular stimulation was able to ini-
tiate the tachyarrhythmia. In addition. multiple morpholog-
ically distinct tachycardias not observed clinically were in-
itiated in 15 (45%) of the 33 patients.
Management and prognosis of inducible tach ycardia
(Table 2). Twenty-one of the 33 patients with inducible
ventricular tachycardia at the time of electrophysiologic study
were managed solely with medical (antiarrhythmic) therapy.
Three groups of medically managed patients are definable
(Fig. 2). The first group (Cases I to 3) consists of three
patients who never underwent repeat electrophysiologic test-
ing. Two of the three patients died of refractory arrhythmias
before leaving the hospital. The third patient died suddenly
16 months after leaving the hospital. The second group
(Cases 4 to 14) consists of 11 patients who were discharged
on medical therapy that did not prevent induction of the
ventricular tachycardia with programmed stimulation but did
prevent spontaneous episodes of sustained ventricular tachy-
cardia during a 2 week period of continuous electrocardio-
graphic monitoring. Eight of these II patients were taking
amiodarone at the time of discharge (Table 2). Eight of the
II patients are alive and 3 have died. Only one patient died
suddenly. The third group of patients (n = 7) was prescribed
medical therapy that proved effective in preventing induc-
tion of the tachycardia during programmed ventricular stim-
ulation. Two of these seven patients died, both suddenly,
8 and 30 months after discharge, respectively. One of the
two patients (Case 16), however, stopped medical therapy
I month before sudden death. After exclusion of this patient
who stopped his medical therapy and the two patients who
did not die suddenly, 13 (72%) of 18 patients treated med-
ically and followed up from 4 to 54 months are alive.
Of the J2 patients who underwe nt surgical therapy (Fig.
2), 5 died perioperatively, I of whom (Case 33) had non-
directed surgery and died of refractory arrhythmias. Of the
remaining seven patients, four are alive, one patient died
suddenly I month after discharge and the remaining two
died of pneumonia and refractory congestive heart failure,
respectively, 4 and 20 months after discharge. With exclu-
sion of the deaths after nondirected surgery and the two
deaths that were not sudden or perioperative, four (44%) of
nine patients followed up from 8 to 42 months are alive.
There is no statistical difference in survival between the
medical versus the surgical patients. Overall, survival for
both groups was 17 (52%) of 33 patients. No significant
difference in ejection fraction (28 versus 32%) or number
of stenosed vessels (2 versus 2.2) exists between medically
and surgically treated patients. Left ventricular aneurysm
was present in 92% of the surgically treated compared with
52% of the medically treated patients (p<0.05).
No inducible tachycardia (Table 3, Fig. 3). Four (57%)
of seven patients with no inducible sustained ventricular
arrhythmia at the time of electrophysiologic study died, all
suddenly. Surgical therapy designed to prevent recurrent
bursts of nonsustained ventricular tachycardia (two patients)
and empiric antiarrhythmic therapy (three patients) did not
prevent sudden death in this small group of patients (Table
3). Short-term survival « 6 months) appears good in pa-
tients with no inducible ventricular tachycardia. Excluding
the single patient who died perioperatively, all of the re-
maining patients survived for at least 7 months. There was
no significant difference in overall survival (52 versus 43%)
in patients with inducible ventricular tachycardia compared
with those with no inducible ventricular tachycardia. Sim-
ilarly. the percent of patients who died either suddenly or
during the perioperative period (33 versus 57%) did not
differ significantly between the two groups.
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*One patient stopped antiarrhythmic therapy 1 month before sudden death.
Figure 2. Graphshowing survival in 21 medically treated patients
with inducible ventricular tachycardia.
Discussion
Clinical Findings
Between 5 and 10% of patients will develop sustained
ventricular arrhythmias in association with acute myocardial
infarction (17-19). Most of these life-threatening arrhyth-
mias occur within the first 12 to 48 hours of onset of pain.
Prompt management with conversion to normal rhythm in
the absence of other associated complications is not asso-
ciated with a worsened prognosis (18-20). A smaller percent
of patients will develop sustained ventricular arrhythmias
subsequent to the initial 48 hours. Rapid ventricular tachy-
cardia frequently precedes degeneration to ventricular fi-
brillation (1,2). In contrast to ventricular tachyarrhythmias
occurring early in the hospital course, epidodes are fre-
quently recurrent, difficult to manage and portend a grave
prognosis, with in-hospital mortality reported as high as
60% (1-3). Similar to previous reports, our patients, in
general, were characterized by spontaneous episodes of rapid
ventricular tachycardia (70% of tachycardia rates being > 180
beats/min) and frequent recurrent episodes (>50% of pa-
tients with >5 recurrences) commonly associated with
hemodynamic collapse.
Factors predictive of ventricular tachycardia. Multi-
vessel coronary artery disease, depressed left ventricular
function, the presence of left ventricular aneurysm and a
complicated initial 48 hours of hospitalization characterized
the patients in our study. Of particular note, one-third of
our patients developed bundle branch block in association
with myocardial infarction. This finding confirms the risk
noted by Lie et al. (1) for the development of late in-hospital
cardiac arrest in those patients experiencing bundle branch
block with their infarction. They reported that the incidence
of bundle branch block was 47% in the 30 patients who
developed late in-hospital cardiac arrest compared with 3%
in 936 control subjects. The incidence of transmural in-
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Figure 3. Graph showing survival in seven patients with nonin-
ducible ventricular tachycardia.
farctions in the general population of patients with myo-
cardial infarction ranges from 60 to 95% (21,22). Trans-
mural injury was characteristic of OUr patient population.
Wald et al. (2) noted that all of their patients with intractable
ventricular tachycardia after infarction had experienced an
anterior myocardial infarction . Among our patients , 38%
experienced preceding inferior myocardial infarction. Thus .
site of infarction alone does not appear to predict or exclude
the development of ventricular tachycardia or fibrillation
soon after a myocardial infarction .
Role of extensive infarction and aneurysm formation.
Sanz et al. (21) determined that angiographic ejection frac-
tion appeared to be the single best predictor of late survival
after infarction. The mean ejection fraction for the 19 non-
survivors was 30% compared with 46% for the 230 survi-
vors. They also noted that the number of diseased coronary
vessels (2.6 diseased vessels for nonsurvivors versus 1.7
diseased vessels for survivors) and the development of se-
vere congestive heart failure during the acute phase of hos-
pitalization (66% for nonsurvivors versus 5% for survivors)
also carried independent prognosti c information . In their
series , 17 of the 19 deaths noted during follow-up study
were sudden. suggesting the development of a ventricular
arrhythmia. It is probable that extensive infarction resulting
in significant myocardial dysfunction and aneurysm for-
mation establishes the necessary anatomic substrate for the
development of sustained, life-threatening ventricular ar-
rhythmias. The development of bundle branch block with
acute infarction typically signifies proximal occlusion of the
left anterior descend ing coronary artery and, therefore. a
massive infarction (l ,23). This fact coupled with the clinical
and angiographic findings in our patients supports the re-
lation between size of infarct and development of arrhythmia.
Electrophysiologic Mechanisms
Reentry versus triggered automaticity. Studies in dogs
(24- 27) after acute coronary occlusion indicate that early
ventricular arrhythmias are due to marked impairment of
conduction producing reentry. Subsequently, during the next
I to 4 days enhanced automaticity of the Purkinje cell may
result in automatic tachycardi a , or if impaired conduction
and heterogeneously prolonged refractoriness persist , reen-
trant arrhythmias ensue (6,27 ,28). During the late infarction
period , reproducible initiation and termination of ventricular
tachycardia have been demonstrated (29,30), suggesting a
reentrant mechanism. Marked impairment in conduction and
heterogeneity of refractoriness is present (29,30) . In human
subjects, little information is available regarding electro-
physiologic mechanisms during acute infarction or in the
periinfarction period. Wellens et al. (7) reported the inability
to initiate ventricular tachycardia in seven patients who de-
veloped ventricular tachycardia within 24 hours of myo-
cardial infarction and in three patients who developed ven-
tricular tachycardia from I day to 5 weeks after infarction.
Of our 40 patients , 33 (82%) had reproducible initiation of
ventricular tachycardia similar in configuration to their clin-
ical arrhythmia. Tachycardias, when tolerated hemody-
namically, were terminated by rapid ventricular pacing. Thus,
in the late infarction period, as reported in the dog, the
mechanism for ventricular tachycardia in human subjects
appear s to be reentry although, admittedly, triggered au-
tomatic ity cannot be excluded with certainty.
Single versus multiple morphology of ventricular
tachycardia. In patients with chronic recurrent ventricular
tachycardia associated with ischemic heart disease, the in-
cidence of inducing ventricular tachycardia whose config-
uration has not been clinically observed has been reported
to be within 5 and 30% (31- 33). Ventricular pacing during
the tachycardia and the admini stration of antiarrhythmic
agents increase s the number of distinct morphologic patterns
observed (32). Of note, 45% of the patients in this series
demonstrated morphologically distinct ventricular tachy-
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cardia induced by programmed stimulation. in addition to
the tachycardia observed clinically. The ability to initiate
ventricular tachycardia in a similar group of patients in
whom no ventricular tachycardia had been previously ob-
served has not been evaluated. The clinical significance of
the induction of additional morphologically distinct ven-
tricular tachycardia remains unknown. The greater incidence
of nonclinical tachycardia compared with that reported pre-
viously may be related to slight differences in stimulation
technique. However, it is also possible that the healing phase
in infarction establishes a greater amount of localized func-
tional conduction delay near the tachycardia circuit, thus
leading to different patterns of ventricular activation.
Overall Survival: Medical Versus
Surgical Management
Short-term versus long-termsurvival. Overall. 32 (80%)
of our 40 patients survived hospitalization. This appears to
be better than the 40 to 60% hospitalization survival rates
reported from other series (I ,2) of patients who develop
ventricular tachycardia/fibrillation associated with cardiac
arrest late in the course of hospitalization . However, long-
term survival (50%) in our patients during a follow-up period
of 20 ± 15 months was less encouraging. particularly be-
cause 8 of the 12 deaths occurring outside the hospital were
sudden. The poor outcome in this patient group approaches
the extremely high mortality rate noted by Wellens et al.
(4) in a similar group of 30 patients who received only
medical therapy for their ventricular tachycardia.
Medical versus surgical management. Wald et al. (2)
noted improved survival in patients with intractable ventric-
ular tachycardia after a myocardial infarction given surgical
rather than medical therapy. Among our patients, many of
whom had multiple episodes of ventricular tachycardia, there
was no significant difference in survival comparing sur-
gically (43%) versus medically (72%) managed patients who
had inducible ventricular tachycardia during electrophysi-
ologic study. The number of stenosed vessels and ejection
fraction did not differ between the two groups of patients.
Although there appears to be a trend toward better survival
in the medically treated patients. caution must be applied
when comparing the two groups. Selection for surgery was
not randomized. Surgically managed patients included those
who had recurrent ventricular tachycardia on all available
medical regimens. In addition, surgery was elected in one
patient because of the concurrent finding of a ventricular
septal defect with significant left to right shunt. Neverthe-
less, the five perioperative deaths in the surgically treated
patients indicate the risk of surgical treatment in the critically
ill patient recovering from a recent myocardial infarction.
Antiarrhythmic therapy. It is not possible to clearly
identify a single "best" or combination of antiarrhythmic
agents that might prove effective in preventing recurrent
ventricular tachycardia in this clinical situation because only
14 patients given medical therapy alone were alive at the
time of this report. Six surviving patients were being treated
with amiodarone, five with quinidine , two with mexiletine,
one with procainamide and one with disopyramide , either
alone or in combination (Table 2). The success of amio-
darone in preventing recurrent arrhythmias in this group of
patients, despite the ability to induce the arrhythmia with
programmed stimulation, appears to be similar to that re-
ported in patients with more chronic forms of coronary
disease (12 ,13).
Inducible Versus Noninducible Tachycardia
Survivors of cardiac arrest with no inducible sustained
ventricular arrhythmias at the time of electrophysiologic
study have been reported to have a good prognosis (34) . It
is, therefore, somewhat surprising that four of the seven
patients without inducible ventricular tachycardia died sud-
denly during follow-up. It is possible that vigor of stimu-
lation may have been the limiting factor in inducing sus-
tained ventricular tachycardia at the time of electrophysiologic
study. However, this is unlikely because six of our seven
patients with non inducible tachycardia received repeat stim-
ulation after administration of isoproterenol, either right
ventricular stimulation with triple extrastimuli or left ven-
tricular stimulation, or both. It is also possible that the
reentrant circuit is protected either anatomically or phys-
iologically. To initiate ventricular tachycardia, single or
multiple stimuli may need to be delivered from a specific
localized site. This may explain the overall good short-term
survival rate in patients with non inducible ventricular tachy-
cardia, given the possibility that the likelihood of sponta-
neous ventricular premature depolarization initiating sus-
tained ventricular tachycardia is just as limited. The other
important possible basis for the high incidence of sudden
death in patients with noninducible ventricular tachycardia
and the overall poor prognosis is that , in some patients , the
tachycardia circuit may not yet be fixed in the healing phase
in the acute infarction. Inducibility and treatment may have
less prognostic value and expected efficacy.
Limitations of the Study
Eighty percent of our patients were referred from other
institutions for evaluation of their life-threatening ventric-
ular arrhythmias after a myocardial infarction. The referral
nature of the group preselects for patients with ventricular
tachycardia that is refractory to therapy and is associated
with life-threatening symptoms. However, it also preselects
for patients who survived their initial recurrent episodes of
hemodynamically compromising tachycardia. This group
may be more likely to survive their subsequent hospital
course, and this may explain the slightly lower incidence





of hospital death in this series when compared with similar
patient populations previously reported on (1-4) .
In addition, electrocardiographic monitoring at the time
of spontaneous episodes of ventricular tachycardia fre-
quently used one or two monitoring leads. Thus, determi-
nation of morphology during spontaneous tachycardia could
only be described in general morphologic terms, that is ,
right or left bundle branch block patterns. When comparing
spontaneous and induced ventricular arrhythmias, subtle dif-
ferences in tachycardia configuration could easily have been
overlooked, thus underestimating the number of nonclinical
morphologically distinctive ventricular tachycardias in-
duced at the time of electrophysiologic study.
Conclusions
The clinical history and electrophysiologic findings of
40 patients who developed sustained ventricular tachyar-
rhythmias between 3 and 65 days after a myocardial in-
farction were reviewed . The following observations can be
made. 1) Most patients who develop these life-threatening
ventricular arrhythmias early after infarction will have a
history of complicated initial 48 hours of hospitalization;
patients developing a bundle branch block associated with
acute infarction are a particularly high risk subgroup (32%
of the study patients) for the development of sustained ven-
tricular arrhythmias . 2) Most patients will have impaired
left ventricular function with an ejection fraction less than
30%, significant multivessel coronary artery disea se and left
ventricular aneurysm . 3) The site of infarction alone does
not appear to predict or exclude the development of ven-
tricular tachycardia or fibrillation ; 38 % of patients had pre-
ceding inferior myocardial infarctions. 4) Most patients (83 %)
will have inducible ventricular arrhythmias with pro-
grammed stimulation , suggesting a reentrant mechanism.
5) Subsequent inducibility of ventricular tachycardia was
not related to the time after infarction at which spontaneous
episodes of ventricular tachycardia were observed. 6) There
is no statistically significant difference in survi val between
medicall y versus surgically treated patients . 7) Although
short-term survival «6 months ) in patients with no induc-
ible ventricular tachycardia is good , long-term survival,
particularly with respect to the risk for sudden death, does
not differ from that in patients with inducible tachycardia .
8) Overall long-term survival remains poor (50%) . This
finding , in addition to the increased risk for sudden death
in the patients with noninducible tachycardia , may be at-
tributed to a changing anatomic substrate during the healing
phase of myocardial infarction .
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